I agree that this site is using cookies. You can find further informations here.
X
HIGASHIYAMA, Ryoko INABA
88  results:
Search for persons X
?
1

Ileal perforation at the site of peritoneal metastasis with..:

SANOMACHI, Tomomi ; YOSHIDA, Tatsuya ; HIGASHIYAMA, Ryoko INABA...
International Cancer Conference Journal.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Passive Smoking–Induced Mutagenesis as a Promoter of Lung C..:

Mochizuki, Akifumi ; Shiraishi, Kouya ; Honda, Takayuki...
Journal of Thoracic Oncology.  19 (2024)  7 - p. 984-994 , 2024
Link: https://doi.org/10.1016/..
 
?
3

In Response: Letter Received From Dr. Charles Ricordel Titl..:

Higashiyama, Ryoko Inaba ; Yoshida, Tatsuya ; Yagishita, Shigehiro.
Journal of Thoracic Oncology.  18 (2023)  2 - p. e16-e17 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Non-specific symptoms as a prodrome of immune-related adver..:

Higashiyama, Ryoko Inaba ; Horinouchi, Hidehito ; Kuchiba, Aya...
Journal of Cancer Research and Clinical Oncology.  149 (2022)  7 - p. 3185-3191 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Safety Implications of Switching Pembrolizumab Dosage From ..:

Higashiyama, Ryoko Inaba ; Yoshida, Tatsuya ; Yagishita, Shigehiro...
Journal of Thoracic Oncology.  17 (2022)  10 - p. 1227-1232 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Atypical radiological presentation of pulmonary invasion of..:

Higashiyama, Ryoko Inaba ; Makita, Shinichi ; Maeshima, Akiko Miyagi.
Japanese Journal of Clinical Oncology.  48 (2018)  3 - p. 298-299 , 2018
Link: https://doi.org/10.1093/..
 
?
7

Response to dabrafenib plus trametinib on a rare BRAF mutat..:

Tamura, Akiko ; Inaba Higashiyama, Ryoko ; Yoshida, Tatsuya..
Thoracic Cancer.  15 (2024)  18 - p. 1454-1456 , 2024
Link: https://doi.org/10.1111/..
 
?
8

Early change in the clearance of pembrolizumab reflects the..:

Ohuchi, Mayu ; Yagishita, Shigehiro ; Jo, Hitomi...
Lung Cancer.  173 (2022)  - p. 35-42 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Non-specific symptoms as a prodrome of immune-related adver..:

Higashiyama, Ryoko Inaba ; Horinouchi, Hidehito ; Kuchiba, Aya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314872/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Performance of Japanese patients in registrational studies:

Goto, Yasushi ; Arakawa, Sayaka ; Shirasawa, Masayuki...
Japanese Journal of Clinical Oncology.  52 (2021)  1 - p. 53-64 , 2021
Link: https://doi.org/10.1093/..
 
?
11

Efficacy of anti-PD-1 antibodies in NSCLC patients with an ..:

Masuda, Ken ; Horinouchi, Hidehito ; Tanaka, Midori...
Journal of Cancer Research and Clinical Oncology.  147 (2020)  1 - p. 245-251 , 2020
Link: https://doi.org/10.1007/..
 
?
12

High doses of antipsychotic polypharmacy are related to an ..:

Sannohe, Takahiro ; Ohnuma, Tohru ; Takeuchi, Masayoshi...
Progress in Neuro-Psychopharmacology and Biological Psychiatry.  76 (2017)  - p. 42-48 , 2017
Link: https://doi.org/10.1016/..
 
?
13

High serum soluble tumor necrosis factor receptor 1 predict..:

Nishimon, Shohei ; Ohnuma, Tohru ; Takebayashi, Yuto...
Progress in Neuro-Psychopharmacology and Biological Psychiatry.  76 (2017)  - p. 145-154 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Medium‐chain triglycerides given in the early stage of mild..:

Kimoto, Ayako ; Ohnuma, Tohru ; Toda, Aiko...
Psychogeriatrics.  17 (2017)  6 - p. 520-521 , 2017
Link: https://doi.org/10.1111/..
 
?
15

Benefits of use, and tolerance of, medium-chain triglycerid..:

Ohnuma, Tohru ; Toda, Aiko ; Kimoto, Ayako...
Clinical Interventions in Aging.  , 2016
Link: https://doi.org/10.2147/..
 
1-15